Compare ARK Genomic Revolution ETF (ARKG) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ProShares UltraPro Short QQQ ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while ProShares UltraPro Short QQQ ETF trades at $39.08. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SQQQ | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $97.60 |
52-Week Low | $23.09 | $36.31 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SQQQ trades at $37.78, down 0.84% on the day, with a bearish technical signal driven by moving averages. The ETF, designed to deliver -3x the daily return of the Nasdaq-100, faces structural decay from daily resets, evidenced by long-term value erosion. Recent news highlights its role as a tactical hedge rather than a long-term holding, with short interest rising 19.4% in March 2026 (Defense World, 2026-04-19).
Outlook remains highly speculative; SQQQ offers potential for short-term gains during Nasdaq declines but carries extreme risk from volatility decay. Investors must actively manage positions due to the ETF's unsuitability for buy-and-hold strategies, with success dependent on precise market timing amid bearish analyst sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
